Sodium Carboxymethyl Cellulose Ophthalmic Solution 0.5% W/V

Sodium Carboxymethyl Cellulose Ophthalmic Solution 0.5% W/V Description Sodium Carboxymethyl Cellulose Ophthalmic Solution 0.5% W/V is a sterile ophthalmic liquid solution of Sodium Carboxymethyl Cellulose 0.5% w/v. The preparation of an ophthalmic solution demands tight control over polymer grade, solution clarity, viscosity, pH, osmolality if relevant, and microbial properties; sterility; and container closure system. Because the formulation is planned for application via a special ophthalmic delivery device, packaging and delivery properties are additional considerations in formulation development. If you are a pharma franchise company looking to extend your ophthalmic product range, you could include this formulation in a PCD pharma franchise range.

Polymer Selection and Ophthalmic Formulation Design

SODIUM CARBOXYMETHYL CELLULOSE The ophthalmic solution is a polymer derived from the cellulose. The grade and physicochemical parameters of the polymer are responsible for the determination of the final properties of the product. The grade of the viscosity and degree of substitution, particles and purity are determining parameters for the qualification of the raw material.

0.5% w/v The polymer is included as part of a carefully formulated aqueous system. The formulation may include pharmaceutical grade water and any other compatible ingredients, in accordance with the approved composition. Buffering agents, tonicity-modifying agents or stabilisers may be included, where necessary, to provide the pre-established formulation properties.

Polymer hydration is an important aspect of development. The order and way in which Sodium Carboxymethyl Cellulose is added to the system can impact flow properties, transparency and undissolved matter.

Preformulation studies can include checking polymer hydration, viscosity, pH response, clarity of solution, and response with other formulation ingredients. The final formulation is chosen once an appropriate physical, chemical, and microbiological profile has been determined.

Solution Preparation and Controlled Hydration

The manufacturing process starts with the meticulous automated dosing, validation of of Sodium Carboxymethyl Cellulose and every other authorized raw material. The pharmaceutical grade water will be produced in accordance with the relevant manufacturing process.

The Sodium Carboxymethyl Cellulose is dispersed into the water phase by a controlled addition process. Depending on the process to be used for addition can be slow to avoid lumps and to allow a more uniform hydration.

Sufficient hydration time is kept within the validated manufacturing process. The mixing speed and time are managed as too much stirring can entrap air in the formulation, and too little stirring will leave the polymer not sufficiently hydrated.

All other soluble ingredients are added according to the pre-selected order. During bulk preparation, the following can be measured; temperature, pH, viscosity and look of solution.

The bulk solution can be suitably filtered to remove any particulate matter which is not compatible with the formulation and validation process. Filtration conditions, filter integrity and process parameters are managed in the sterile manufacturing system.

The final bulk formulation is moved by controlled routes to the sterile filling stage with suitable environmental and microbiological controls.

Sterile Processing and Aseptic Filling

Defining the Ideal for Your Sterility is one of the essential quality requirement for any ophthalmic product. Based on formulation and validated manufacturing design, the process will have to include sterilization and/or sterile filtration and aseptic filling.

Manufacturing area, equipment, personnel, and key process areas are controlled. Environmental monitoring is conducted and this monitors the microbiological and particulate conditions within the key process areas by an approved monitoring schedule.

Where sterile filtration is applied, the choice of membrane and filtration process should be validated for the formulation. The integrity of the filter can be established by the appropriate pre-use or post-use test using the validated process.

Filling Volume are filled using controlled equipment that dispenses the required volume into each ophthalmic container. Filling accuracy and Line performance are monitored using in-process control measures.

For the container and closure, the components should be prepared according to validated procedures prior to the aseptic filling operation. The container must be capped as soon as possible after filling to maintain the correct container-closure integrity.

Process documentation documents key parameters from bulk prep to fill and seal to provide traceability of each production run.

Clarity, Viscosity and Finished-Product Testing

Physical, chemical and microbiological tests are conducted to control the quality of the product (Sodium Carboxymethyl Cellulose Ophthalmic Solution 0.5% W/V).

The prepared solution could be examined for visual appearance and clarity to ensure that it does not contain any unacceptable visible particles or undissolved solids. Testing for viscosity is important as Sodium Carboxymethyl Cellulose is a viscosity modulating polymer and differences can affect the viscosity of the formulation.

PH and other physicochemical parameters is assessed as per the product specification. The assay or identification testing can be carried out by using an appropriate analytical method for confirming the concentration of Sodium Carboxymethyl Cellulose as listed when a defined quantitative method exists.

As a finished-product quality assessment for a sterile ophthalmic dosage form, you will want to test for sterility. For appropriate products, a bacterial endotoxin test may be required in the finished-product quality assessment.

Other tests may include, but are not limited to, particulate matter, fill volume, container integrity, viscosity, osmolality (if relevant) and level of preservative, if a preservative has been added.

Analytical instruments are qualified, calibrated and maintained in accordance with approved laboratory procedures. Laboratory results and observations are recorded in the batch quality records and reviewed prior to final release.

Container Compatibility and Stability Program

Stability studies establish whether the Sodium Carboxymethyl Cellulose Ophthalmic Solution 0.5% W/V remains within the specifications set for it at the time of manufacture, for the proposed shelf life.

Stability samples can be subject to assaying for appearance, clarity, pH, viscosity, assay, particulate quality, microbial quality, sterility if relevant and other relevant quality attributes.

Packaging compatibility An ophthalmic solution formulation is in contact with the primary container and dispensed every time it is used. The container material should be compatible with the formulation.

Ophthalmic solutions can be presented in appropriate containers of plastic suitable for sterile preparation, in multidose bottles for dispensing or in other appropriate packaging systems, in accordance with the design of the product. Container-closure integrity studies may assess the integrity of the package for maintaining the sterility of the preparation.

The dispensing system and closure system may also be assessed in the multidose presentation in relation to reproducible delivery and the preservation of the product integrity during the period of use.

The packaging components should be checked for quality by the required process before filling. The finished package should offer adequate protection for transportation, storage and handling.

Apart from our specialized range of Eye Care products, we have developed and expanded our diverse portfolio in other medical sectors like Dermatology, Respiratory, Gynecological, Diabetology, Cardiology and Dental. We offer an exclusive PCD Pharma Franchise for our entire array of Ophthalmic and other portfolio products. Our business model is aimed to create entrepreneurs who want to make a career in the pharmaceutical sector.

Sodium Carboxymethyl Cellulose Ophthalmic Solution 0.5% W/V can be included in a wide-ranging pharmaceutical ophthalmic range by means of gradually devised formulation development, sterile production, validated analytical methods and packaging systems. For PCD Pharma Franchise companies, ophthalmic preparations need to be administered more meticulously for batch documentation, container compatibility, particulate levels and sterility.

A systematically developed product-development file might contain specifications for the polymers, testing requirements for raw-materials, supplier qualifications, formulation profile, manufacture procedures, controls for sterile-processing, analytical data, packaging requirements, and protocols for the stability.

Special emphasis should be paid on hydration and viscosity profile of Sodium Carboxymethyl Cellulose solution. Proper dosing, mixing, sufficient hydration and filtration may ensure a stable solution quality.

Quality assurance should oversee the entire manufacturing process, from incoming raw materials through dispensing, solution preparation, filtration, sterile filling and container closure, inspection, laboratory testing and packaging through the final batch review.

For commercial product management, the approved formulation and concentration should be depicted uniformly in packaging artwork, product catalogues, technical documents and electronic file formats. Correct product data will help ensure consistency between production specifications and the commercial information.